Israeli drugmaker says TEV-408, an anti-IL-15 antibody designed for quarterly dosing, improved skin pigmentation in an early-stage study and will move into Phase 2b development later this year | Read More in ynet – Culture
US strikes southern Iran in response to Iranian attacks in the Strait of Hormuz
Haredi protests against Jerusalem Light Rail continue, reports of over NIS 400 million in damage
UK summons senior Iranian diplomat over stabbing of Iran International journalist in London
Bernie Sanders urges Platner to quit Maine Senate race as Democrats vie to succeed him‘Unconditional support’ US support for Netanyahu was a mistake, Rahm Emanuel saysNigel Farage resigns from parliament to force ‘people vs establishment’ vote
How a TV regulator became the center of Israel’s constitutional crisis
Yoseph Haddad prepares political run as parties court himUS strikes southern Iran in response to Iranian attacks in the Strait of Hormuz‘Unconditional support’ US support for Netanyahu was a mistake, Rahm Emanuel saysNigel Farage resigns from parliament to force ‘people vs establishment’ voteRahm Emanuel: Pursuit of Greater Israel as ‘fanatical’ as the chant ‘from the river to the sea’US launches ‘powerful strikes’ against Iran
